Retatrutide is a novel triple agonist that targets three key receptors involved in metabolic regulation: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors (GCGR). By simultaneously activating these receptors, Retatrutide offers a synergistic effect that improves insulin secretion, reduces appetite, enhances energy expenditure, and promotes fat metabolism. This multi-receptor mechanism enables it to significantly improve blood glucose control and support substantial weight loss. Early clinical trials have shown that Retatrutide may offer superior outcomes compared to existing therapies for obesity and type 2 diabetes.
| Product Name | Retatrutide Peptide |
| Shelf Life | 2 Years |
| Form | Peptide |
| Indication | Weight Loss |
| Dosage | 1mg~12mg/week |
| Active Ingredient | Retatrutide |
| Storage Conditions | Store At 2-25°C |
| Packaging | 10mg/vial, 15mg/vial, 20mg/vial, 30mg/vial, 40mg/vial |
Retatrutide is a triple hormone receptor agonist that targets GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and GCGR (glucagon receptor). Its primary function is to regulate metabolism and support the treatment of obesity and type 2 diabetes. Here's how it works:
1. Improves Blood Glucose Control:
– Stimulates insulin secretion in a glucose-dependent manner.
– Reduces glucagon levels when blood sugar is high.
2. Suppresses Appetite:
– Acts on the brain’s appetite centers to reduce hunger and increase satiety.
3. Enhances Energy Expenditure:
– Activation of the glucagon receptor promotes calorie burning and fat metabolism.
4. Promotes Significant Weight Loss:
– By combining these effects, Retatrutide helps reduce body weight more effectively than single or dual agonists.
For high value products, please select air shipping and express delivery for safety.
